Review
Open access
Jul 2026
Biomarkers of treatment response in rheumatoid arthritis: from conventional markers to tissue immunophenotype
It is concluded that precision medicine in RA will require integrated biomarker panels combining clinical, pharmacological, molecular, and synovial tissue data, and the development of scalable, externally validated, and clinically interpretable models capable of assigning synovial endotypes and supporting mechanism-based therapeutic selection.
N. A. Batashkov, E. Gerasimova, D. Gerasimova et al.
· Frontiers in Immunology · 0 citations